4.6 Article

Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder

Kristine Farmen et al.

Summary: This study found abnormal monocytic markers in the peripheral blood of iRBD patients, which were associated with brain inflammation and neuronal dysfunction. The findings suggest a cross-talk between the peripheral and brain in synucleinopathy-related disorders.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia

Maria Antonella Zingaropoli et al.

Summary: Elevated levels of sCD163 and sCD14 were observed in COVID-19 patients, particularly in those developing ARDS, with correlations to typical inflammatory markers. This suggests their potential use in assessing disease progression risk. Lower percentages of monocytes and DCs in COVID-19 patients, especially in the ARDS group, indicate their role in disease severity.

FRONTIERS IN IMMUNOLOGY (2021)

Review Endocrinology & Metabolism

The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review

Zhila Semnani-Azad et al.

Summary: The systematic review examined the relationship between sCD163 and T2DM, insulin resistance, and beta-cell dysfunction. Most studies demonstrated a positive association between sCD163 and insulin resistance, with mixed findings on beta-cell function. Studies also explored the impact of weight-reducing interventions and supplementation on sCD163 levels.

OBESITY REVIEWS (2021)

Review Geriatrics & Gerontology

Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke

Yimeng Xue et al.

Summary: Ischemic stroke, the second leading cause of death and disability globally, is found to be associated with immunity and inflammation in its pathobiology. The focus has shifted towards promoting microglial polarization towards the M2 phenotype after stroke, as microglia play a crucial role in the nervous system defense.

AGING AND DISEASE (2021)

Article Medicine, General & Internal

Leukocyte Biomarkers for the Differential Diagnosis of Mild Acute Ischemic Stroke, Transient Ischemic Attack, and Stroke Mimic

Megan E. Cavrak et al.

Summary: This study found that the neutrophil percentage was the only significant biomarker that differed significantly between study groups. After adjusting for confounding variables such as age, gender, and medical history, patients with mild AIS were 5.3 times more likely than TIA cases to have a neutrophil percentage above the normal range. These results suggest that clinicians may use neutrophil percentage as an additional tool to differentiate between mild AIS and TIA.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Endocrinology & Metabolism

Transcriptomic characterization of microglia activation in a rat model of ischemic stroke

Wenjun Deng et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)

Article Clinical Neurology

The predictive value of CSF multiple assay in multiple sclerosis: A single center experience

C. De Fino et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Review Biochemistry & Molecular Biology

CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects

Anders Etzerodt et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Article Clinical Neurology

Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke

Mathias Gelderblom et al.

STROKE (2009)